Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vericel CorpVCEL · Entity 4481 | Principal Accounting Officer | July 30, 2026 | July 31, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vericel Corp
Report date July 30, 2026 · Filed July 31, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,078 |
Last balance in matching sequence
After 2026-07-30 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
6 source rowsRow 1 · 2026-07-30 · Exercise / conversion · Acquired 1,500 · Balance 2,578 F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Row 2 · 2026-07-30 · Sale · Disposed 1,500 · Balance 1,078 F2: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025. F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Row 3 · 2026-07-30 · Exercise / conversion · Acquired 2,500 · Balance 3,578 F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Row 4 · 2026-07-30 · Sale · Disposed 2,500 · Balance 1,078 F2: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025. F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Row 5 · 2026-07-30 · Exercise / conversion · Acquired 500 · Balance 1,578 F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Row 6 · 2026-07-30 · Sale · Disposed 500 · Balance 1,078 F2: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025. F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.90 · Expires 2032-02-18 | Direct | 2,698 |
Reported balance
After 2026-07-30 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-07-30 · Exercise / conversion · Acquired 1,500 · Balance 2,698 F3: These options, representing the right to purchase 4,198 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.82 · Expires 2033-02-17 | Direct | 4,000 |
Reported balance
After 2026-07-30 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-07-30 · Exercise / conversion · Acquired 2,500 · Balance 4,000 F4: These options, representing the right to purchase 9,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.82 · Expires 2033-02-17 | Direct | 3,500 |
Reported balance
After 2026-07-30 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-07-30 · Exercise / conversion · Acquired 500 · Balance 3,500 F4: These options, representing the right to purchase 9,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.
F3: These options, representing the right to purchase 4,198 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted
F4: These options, representing the right to purchase 9,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 28, 2025 Filed Jan 30, 2025 21:05 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 3,908 | $61.99 | $242,256.92 |
DisclosureSEC source: 0001140361-25-002441 · form4.xml · nonDerivative · entry 2 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,206 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 21:05 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 3,908 | $48.80 | $190,710.40 |
DisclosureSEC source: 0001140361-25-002441 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:06 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 568 | $41.90 | $23,799.20 |
DisclosureSEC source: 0001140361-24-042559 · form4.xml · nonDerivative · entry 3 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,124 F4 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:06 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 937 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-24-042559 · form4.xml · derivative · entry 4 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 938 Underlying: Common Stock · 937 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F7 · price: The Fair Market Value of the vested derivative securities is $42.25 per share. F1 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on September 30, 2021. The remaining RSUs will vest on September 30, 2025. F6 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:06 UTC | Vericel Corp VCEL · Entity 4481 | Tax withholdingCommon Stock | 369 | $42.25 | $15,590.25 |
DisclosureSEC source: 0001140361-24-042559 · form4.xml · nonDerivative · entry 2 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,692 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:06 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 937 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-042559 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on September 30, 2021. The remaining RSUs will vest on September 30, 2025. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:05 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 545 | $45.00 | $24,525.00 |
DisclosureSEC source: 0001140361-24-032762 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,033 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:08 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 1,634 | $45.00 | $73,530.00 |
DisclosureSEC source: 0001140361-24-012610 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,400 F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:05 UTC | Vericel Corp VCEL · Entity 4481 | GrantRestricted Stock Unit · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-009487 · form4.xml · derivative · entry 2 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 22, 2025. The remaining RSUs will vest in annual installments on February 22, 2026, February 22, 2027, and February 22, 2028, respectively. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:05 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $48.31 | $0.00 |
DisclosureSEC source: 0001140361-24-009487 · form4.xml · derivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2034-02-22 F1 · derivative.exercise_date: These options shall begin vesting on February 22, 2024 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:06 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 420 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-24-009029 · form4.xml · derivative · entry 6 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 840 Underlying: Common Stock · 420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F7 · price: The Fair Market Value of the vested derivative securities is $49.50 per share. F4 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2025, and February 18, 2026, respectively. F6 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:06 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-24-009029 · form4.xml · derivative · entry 5 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F7 · price: The Fair Market Value of the vested derivative securities is $49.50 per share. F1 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively. F6 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:06 UTC | Vericel Corp VCEL · Entity 4481 | Tax withholdingCommon Stock | 169 | $49.50 | $8,365.50 |
DisclosureSEC source: 0001140361-24-009029 · form4.xml · nonDerivative · entry 4 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,034 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:06 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-009029 · form4.xml · nonDerivative · entry 3 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2025, and February 18, 2026, respectively. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:06 UTC | Vericel Corp VCEL · Entity 4481 | Tax withholdingCommon Stock | 1,117 | $49.50 | $55,291.50 |
DisclosureSEC source: 0001140361-24-009029 · form4.xml · nonDerivative · entry 2 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,783 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:06 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-009029 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 31, 2023 Filed Feb 13, 2024 11:00 UTC | Vericel Corp VCEL · Entity 4481 | GrantCommon Stock | 95 | $28.21 | $2,679.95 |
DisclosureSEC source: 0001140361-24-007192 · form5.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,400 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:06 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 662 | $37.70 | $24,954.09 |
DisclosureSEC source: 0001140361-23-053858 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,305 F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:05 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 938 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-046932 · form4.xml · derivative · entry 3 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,875 Underlying: Common Stock · 938 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F6 · price: The Fair Market Value of the vested derivative securities is $33.19 per share. F1 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on September 30, 2021. The remaining RSUs will vest in annual installments on September 30, 2024, and September 30, 2025, respectively. F5 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:05 UTC | Vericel Corp VCEL · Entity 4481 | Tax withholdingCommon Stock | 276 | $33.19 | $9,160.44 |
DisclosureSEC source: 0001140361-23-046932 · form4.xml · nonDerivative · entry 2 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,858 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:05 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 938 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-046932 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on September 30, 2021. The remaining RSUs will vest in annual installments on September 30, 2024, and September 30, 2025, respectively. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 18, 2023 Filed Feb 23, 2023 03:00 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 419 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-006604 · form4.xml · derivative · entry 6 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,260 Underlying: Common Stock · 419 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F8 · price: The Fair Market Value of the vested derivative securities is $29.82 per share. F1 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026. F7 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 18, 2023 Filed Feb 23, 2023 03:00 UTC | Vericel Corp VCEL · Entity 4481 | Tax withholdingCommon Stock | 162 | $29.82 | $4,830.84 |
DisclosureSEC source: 0001127602-23-006604 · form4.xml · nonDerivative · entry 2 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 932 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 18, 2023 Filed Feb 23, 2023 03:00 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 419 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006604 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 17, 2023 Filed Feb 23, 2023 03:00 UTC | Vericel Corp VCEL · Entity 4481 | GrantRestricted Stock Unit · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006604 · form4.xml · derivative · entry 5 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F8 · price: The Fair Market Value of the vested derivative securities is $29.82 per share. F6 · derivative.exercise_date: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 17, 2024. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively. F7 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 17, 2023 Filed Feb 23, 2023 03:00 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (Right to Buy) · Derivative | 6,187 | $0.00 Strike: $29.82 | $0.00 |
DisclosureSEC source: 0001127602-23-006604 · form4.xml · derivative · entry 4 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,187 Underlying: Common Stock · 6,187 shares Expires 2033-02-17 F4 · derivative.exercise_date: These options shall begin vesting on February 17, 2023 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 17, 2023 Filed Feb 23, 2023 03:00 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (Right to Buy) · Derivative | 2,813 | $0.00 Strike: $29.82 | $0.00 |
DisclosureSEC source: 0001127602-23-006604 · form4.xml · derivative · entry 3 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,813 Underlying: Common Stock · 2,813 shares Expires 2033-02-17 F4 · derivative.exercise_date: These options shall begin vesting on February 17, 2023 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:04 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 330 | $31.00 | $10,230.00 |
DisclosureSEC source: 0001127602-23-003302 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675 F1 · shares: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| October 14, 2022 Filed Oct 18, 2022 20:01 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 331 | $25.47 | $8,430.57 |
DisclosureSEC source: 0001127602-22-024068 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 875 F1 · shares: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:57 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 937 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-023522 · form4.xml · derivative · entry 3 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,813 Underlying: Common Stock · 937 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F6 · price: The Fair Market Value of the vested derivative securities is $23.20 per share. F1 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on September 30, 2021. The remaining RSUs will vest in annual installments on September 30, 2023, September 30, 2024, and September 30, 2025, respectively. F5 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:57 UTC | Vericel Corp VCEL · Entity 4481 | Tax withholdingCommon Stock | 276 | $23.20 | $6,403.20 |
DisclosureSEC source: 0001127602-22-023522 · form4.xml · nonDerivative · entry 2 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 927 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:57 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 937 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023522 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on September 30, 2021. The remaining RSUs will vest in annual installments on September 30, 2023, September 30, 2024, and September 30, 2025, respectively. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 18, 2022 Filed Mar 11, 2022 21:06 UTC | Vericel Corp VCEL · Entity 4481 | GrantRestricted Stock Unit · Derivative | 1,679 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-22-000721 · primary_01.xml · derivative · entry 2 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,679 Underlying: Common Stock · 1,679 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 18, 2023. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026, respectively. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 18, 2022 Filed Mar 11, 2022 21:06 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (right to buy) · Derivative | 4,198 | $0.00 Strike: $34.90 | $0.00 |
DisclosureSEC source: 0001593968-22-000721 · primary_01.xml · derivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,198 Underlying: Common Stock · 4,198 shares Expires 2032-02-18 F1 · derivative.exercise_date: These options shall begin vesting on February 18, 2022 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.